Thu, Mar 5, 2015, 4:22 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. (SNTA) Message Board

  • baboooooooz baboooooooz May 7, 2013 12:35 PM Flag


    BMO Capital downgraded Synta Pharma. (NASDAQ: SNTA) from Outperform to Market Perform with a price target of $9.00 (from $18.00) following the resignation of the company's R&D President Sumant Ramachandra.

    For an analyst ratings summary and ratings history on Synta Pharma. click here. For more ratings news on Synta Pharma. click here.

    Shares of Synta Pharma. closed at $9.37 yesterday, with a 52 week range of $3.57-$11.88.

2.67+0.24(+9.88%)4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.